Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of ETV6‑NTRK3 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of secretory carcinoma of the breast Applicable only once per lifetime